Investigating heart and kidney damage in COVID-19 survivors
Cardiovascular Risk, Vascular and Kidney Damage in COVID-19 Survivors
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-10995283
This study is looking at how COVID-19 might affect heart and kidney health over time, and it's for people who have recovered from COVID-19, as well as others without the virus, to help us understand any risks they might face.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10995283 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the long-term effects of COVID-19 on cardiovascular and kidney health. It aims to identify how COVID-19 may lead to increased risks of heart disease and kidney damage in survivors. The study will involve a large cohort of COVID-19 survivors and matched controls, utilizing electronic health records to track cardiovascular events and perform detailed assessments of vascular and renal health. By examining these outcomes, the research seeks to uncover risk factors that contribute to adverse health effects following COVID-19 infection.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have recovered from COVID-19 and are experiencing or at risk for cardiovascular or kidney issues.
Not a fit: Patients who have not had COVID-19 or those without any cardiovascular or kidney concerns may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved monitoring and treatment strategies for cardiovascular and kidney complications in COVID-19 survivors.
How similar studies have performed: Other research has indicated that respiratory infections can lead to long-term cardiovascular issues, suggesting that this investigation could yield valuable insights.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHIRINOS MEDINA, JULIO ALONSO — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: CHIRINOS MEDINA, JULIO ALONSO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: acute coronary syndrome, after COVID-19 infection, after infection by SARS-CoV-2, after SARS-CoV-2 infection, after SARS-CoV2 infection